Navigation Links
Lotrel, a Single-Pill Combination for Treating High Blood Pressure, Reduced Cardiovascular Events by 20% in High-Risk Patients
Date:3/31/2008

ts, or to any ACE inhibitor or for patients taking LOTREL, amlodipine. Do not take the benazepril and HCTZ combination if you have a history of reduced urine output, or have allergic reactions to certain drugs known as sulfonamides and tell your doctor if you have liver problems, lupus or if you take lithium. Your doctor or pharmacist can give you a complete list of the ingredients in LOTREL or the benazepril and HCTZ combination.

In rare cases with LOTREL or the benazepril and HCTZ combination, a potentially life-threatening allergic reaction (swelling of the mouth and throat) can occur. This potentially dangerous swelling of the mouth and throat has been reported more often in African American patients receiving ACE inhibitors than in non-African American patients.

The most serious side effect with LOTREL and the benazepril and HCTZ combination is low blood pressure.

The most common side effects in patients taking LOTREL and the benazepril and HCTZ combination include cough, dizziness, and headache, additionally with the benazepril and HCTZ combination fatigue and additionally with LOTREL, edema (swelling of the feet, ankles, legs, or hands).

Please see full prescribing information about Lotrel and Lotensin HCT at http://www.pharma.us.novartis.com or contact Christine Cascio at 862-778-8026 or christine.cascio@novartis.com. The combination doses of benazepril and HCTZ

40/12.5 mg and 40/25 mg used in this study were investigational and do not have approved prescribing information available.

About high blood pressure and treatment

High blood pressure increases a person's risk of experiencing a cardiovascular event. For example, it has been reported that the risk of heart attack and stroke doubles with every 20/10 mmHg increase in blood pressure, starting at 115/75 mmHg. Blood pressure treatment guidelines s
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Abbotts Phase III Studies of Investigational TriLipix(TM) (ABT-335), in Combination With Statins, Meets Primary Endpoints on Improving LDL, Triglycerides and HDL
2. ISTA Pharmaceuticals Announces Physician-Sponsored Clinical Study of Xibrom(TM) Combination Therapy with Lucentis(R)
3. New 48-Week Efficacy and Safety Data Presented for INTELENCE(TM) (etravirine) as Part of HIV Combination Therapy
4. Cogentus Pharmaceuticals Begins Clinical Study to Confirm the Full Antiplatelet Benefit of New Combination Medicine CGT-2168
5. First Patient Enrolled in Cogentus Pharmaceuticals Pivotal Phase 3 Trial of Novel Combination Medicine
6. Pharmion and MethylGene Start Phase 2 Combination Clinical Trial With MGCD0103 and Vidaza(R) in Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma
7. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
8. New Drug Combination is Able to Eradicate Breast Metastases in Mice
9. Data Presented at 2007 ASH Meeting Demonstrate Activity of Forodesine HCl as a Single Agent or in Combination With Bendamustine in Certain Types of Leukemia and Lymphoma
10. Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine(R) (VNP40101M) in Combination with Stem Cell Transplantation
11. Avicena Announces Positive Phase II Data for a Combination Trial Involving AL-08 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... 5, 2015 Vermillion, Inc. (Nasdaq: ... on gynecologic disease, announced today it will report ... market open on Wednesday, March 25, 2015, followed ... 8:30am Eastern. Conference Call & Webcast: ... Pacific Domestic: , 800-753-9057International: , 913-981-5571Conference ID: , ...
(Date:3/5/2015)... , March 5, 2015  As the ... of regulations, Ethics & Compliance professionals are placing ... a new survey issued today by LRN, the ... education. An overwhelming majority of respondents expressed that ... most important component of E&C training programs (57%), ...
(Date:3/5/2015)... 5, 2015  Sanomedics, Inc. (OTC: SIMH, SIMHD) ("Sanomedics" ... on developing, manufacturing, and acquiring cutting-edge technology, products and ... will be exhibiting at booth # 709 at the ... (NAPNAP) taking place on March 11-13, 2015 at Caesars ... The 36 th annual NAPNAP ...
Breaking Medicine Technology:Vermillion to Report Fourth Quarter and Year-End 2014 Financial Results and Host an Investor Conference Call on March 25 2Pharmaceutical Ethics & Compliance Professionals Place Company Values Front and Center 2Pharmaceutical Ethics & Compliance Professionals Place Company Values Front and Center 3Sanomedics to Showcase the Caregiver at National Association of Pediatric Nurse Practitioners Conference 2Sanomedics to Showcase the Caregiver at National Association of Pediatric Nurse Practitioners Conference 3
... Announces Clinical Trial Plans for 4Q07/1Q08, DALLAS, ... ACCP) provided today an update on the clinical,development ... prodrug, and,announced plans for additional human clinical trials ... ongoing clinical trial in recurrent ovarian,cancer patients, designed ...
... ... Study -, ... has initiated a multi-dose, Phase 2a clinical trial with,its monoclonal antibody ... dose-escalation study is,designed to evaluate the safety and tolerability of multiple ...
Cached Medicine Technology:Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac 2Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac 3Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac 4MedImmune Initiates Phase 2a Multi-Dose Study in Patients with Asthma 2
(Date:3/5/2015)... York, NY (PRWEB) March 05, 2015 ... move forward in a Pennsylvania mass tort litigation ... Pleas, where a jury has begun hearing testimony ... that the atypical antipsychotic medication can cause gynecomastia, ... the case in question was filed on behalf ...
(Date:3/5/2015)... Central Nebraska Imaging (CNI) is pleased to announce ... logo and optimized website. , CNI’s new ... expert diagnostic imaging, centered on patient care. The new ... a resource for Nebraska patients and a tool for ... referral functionality, video content and resources to understand health ...
(Date:3/5/2015)... HomeCEUConnection.com is proud to support Nutrition ... their nutrition CEUs. To raise awareness on ... is offering 10% off selected nutrition CEU ... . , High Quality Continuing Education for ... continuing education courses for Physical Therapists, Physical ...
(Date:3/5/2015)... On March 2, 2015, NBC News ... the Rise, Plastic Surgeons Say,” that comments on the ... Aesthetic Plastic Surgery and the American Society ... year-over-year doubling of surgical butt augmentations performed in 2014. ... article, this increase can be attributed to the social ...
(Date:3/5/2015)... Michigan (PRWEB) March 05, 2015 In ... opportunity to shatter myths about drug and alcohol abuse ... has released a Fact Sheet with information on some ... Launched in 2010 by the National Institute on Drug ... and alcohol aims to counteract the illusions that teens ...
Breaking Medicine News(10 mins):Health News:Risperdal Lawsuits Move Forward in Pennsylvania, as Bernstein Liebhard LLP Comments on Start of Second Gynecomastia Trial 2Health News:Risperdal Lawsuits Move Forward in Pennsylvania, as Bernstein Liebhard LLP Comments on Start of Second Gynecomastia Trial 3Health News:Central Nebraska Imaging Center Gets Rebranding 2Health News:HomeCEUConnection.com Offers Nutrition CEUs this March to Celebrate Nutrition Month 2Health News:The Kim Kardashian and Jennifer Lopez Effect: Butt Augmentations Double from 2013 to 2014 2Health News:A Forever Recovery Issues New Tips for Sobriety for National Drug Facts Week 2
... are no easy discounts because of where you live or whether ... is totally out of your control.  Here are a few things ... Do the Math: While a plan with a lower premium ... come with either higher co-pays (the part you pay out-of-pocket at ...
... CINCINNATI, Dec. 11, 2008 The Procter & Gamble,Company ... Analyst Meeting today in New York City,beginning at 8:30 ... Chief,Executive Officer A.G. Lafley and the Company,s executive management ... and long-term strategies,capabilities and growth opportunities. , ...
... Physician and top stress expert advises getting a flu shot and ... ... Nottingham, UK (PRWEB) December 11, 2008 -- During this time of ... combine with the pressures of the holiday season. But top ...
... discovered that scientists in Australian were using a skin cancer cream ... benefits to mesothelioma patients. In a majority of the mice, scientists ... ... Denver, CO (PRWEB) December 11, 2008 -- LegalView, the number one ...
... of Utah researchers have developed an automobile ignition key that ... messages while driving. , The university has obtained provisional patents ... company that hopes to see it on the market within ... key plus a yet-undetermined monthly service fee. , "The ...
... (Nasdaq: ACEL ) today reported its financial results for ... The company recorded a net loss of approximately $2.8 ... fiscal quarter ended Oct. 31., compared to a net loss of ... the first quarter of fiscal 2008. Research and development expenses ...
Cached Medicine News:Health News:How to Save Money on Health Insurance 2Health News:P&G To Share Confidence in Long-Term Strategies and Goals at 2008 Analyst Meeting 2Health News:P&G To Share Confidence in Long-Term Strategies and Goals at 2008 Analyst Meeting 3Health News:P&G To Share Confidence in Long-Term Strategies and Goals at 2008 Analyst Meeting 4Health News:Don't 'Worry Yourself Sick' This Winter 2Health News:Don't 'Worry Yourself Sick' This Winter 3Health News:LegalView Reports That Skin Cancer Drug May Offer Treatment to Mesothelioma Patients 2Health News:LegalView Reports That Skin Cancer Drug May Offer Treatment to Mesothelioma Patients 3Health News:LegalView Reports That Skin Cancer Drug May Offer Treatment to Mesothelioma Patients 4Health News:Car key jams teen drivers' cell phones 2Health News:Car key jams teen drivers' cell phones 3Health News:Car key jams teen drivers' cell phones 4Health News:Alfacell Reports Financial Results for First Quarter of Fiscal 2009 2Health News:Alfacell Reports Financial Results for First Quarter of Fiscal 2009 3Health News:Alfacell Reports Financial Results for First Quarter of Fiscal 2009 4Health News:Alfacell Reports Financial Results for First Quarter of Fiscal 2009 5
... Artis dTC is a versatile solution designed ... department from preparation to diagnosis and ... With AXIOM Artis dTC, your cath lab ... department that leaves you free to concentrate ...
... BC is a biplane cardiovascular ... ideal for cardiological diagnostics and ... architecture enables you to optimally ... focus on:, Interventional cardiology, ...
MAGNETOM Symphony, an imaging system that offers 1.5T performance and top image quality in a short bore design....
... you to scan every beating heart at any ... possible. A scanner using two X-ray sources ... provides one-stop diagnosis in acute care; even with ... Combined with the Cardiac Engine, a unique combination ...
Medicine Products: